AAAAAA

   
Results: 1-11 |
Results: 11
ADENOVIRUS-MEDIATED P53 GENE-THERAPY AND PACLITAXEL HAVE SYNERGISTIC EFFICACY IN MODELS OF HUMAN HEAD AND NECK, OVARIAN, PROSTATE, AND BREAST-CANCER
Authors: NIELSEN LL LIPARI P DELL J GURNANI M HAJIAN G
Citation: Ll. Nielsen et al., ADENOVIRUS-MEDIATED P53 GENE-THERAPY AND PACLITAXEL HAVE SYNERGISTIC EFFICACY IN MODELS OF HUMAN HEAD AND NECK, OVARIAN, PROSTATE, AND BREAST-CANCER, Clinical cancer research, 4(4), 1998, pp. 835-846
ADENOVIRUS-MEDIATED P53 GENE-THERAPY AND PACLITAXEL HAVE SYNERGISTIC EFFICACY IN MODELS OF HUMAN HEAD AND NECK, OVARIAN, PROSTATE, AND BREAST-CANCER
Authors: NIELSEN LL LIPARI P DELL J GURNANI M HAJIAN G
Citation: Ll. Nielsen et al., ADENOVIRUS-MEDIATED P53 GENE-THERAPY AND PACLITAXEL HAVE SYNERGISTIC EFFICACY IN MODELS OF HUMAN HEAD AND NECK, OVARIAN, PROSTATE, AND BREAST-CANCER, Clinical cancer research, 4(4), 1998, pp. 835-846
RECOMBINANT E1-DELETED ADENOVIRUS-MEDIATED GENE-THERAPY FOR CANCER - EFFICACY STUDIES WITH P53 TUMOR-SUPPRESSOR GENE AND LIVER HISTOLOGY INTUMOR XENOGRAFT MODELS
Authors: NIELSEN LL GURNANI M SYED J DELL J HARTMAN B CARTWRIGHT M JOHNSON RC
Citation: Ll. Nielsen et al., RECOMBINANT E1-DELETED ADENOVIRUS-MEDIATED GENE-THERAPY FOR CANCER - EFFICACY STUDIES WITH P53 TUMOR-SUPPRESSOR GENE AND LIVER HISTOLOGY INTUMOR XENOGRAFT MODELS, Human gene therapy, 9(5), 1998, pp. 681-694
A RECOMBINANT ADENOVIRAL VECTOR EXPRESSING FULL-LENGTH HUMAN RETINOBLASTOMA SUSCEPTIBILITY GENE INHIBITS HUMAN TUMOR-CELL GROWTH
Authors: DEMERS GW HARRIS MP WEN SF ENGLER H NIELSEN LL MANEVAL DC
Citation: Gw. Demers et al., A RECOMBINANT ADENOVIRAL VECTOR EXPRESSING FULL-LENGTH HUMAN RETINOBLASTOMA SUSCEPTIBILITY GENE INHIBITS HUMAN TUMOR-CELL GROWTH, Cancer gene therapy, 5(4), 1998, pp. 207-214
P53 TUMOR-SUPPRESSOR GENE-THERAPY FOR CANCER
Authors: NIELSEN LL MANEVAL DC
Citation: Ll. Nielsen et Dc. Maneval, P53 TUMOR-SUPPRESSOR GENE-THERAPY FOR CANCER, Cancer gene therapy, 5(1), 1998, pp. 52-63
ADENOVIRUS-MEDIATED P53 GENE-THERAPY SYNERGIZES WITH PACLITAXEL AGAINST HUMAN OVARIAN, MAMMARY, PROSTATE, HEAD AND NECK, AND LIVER-CANCER
Authors: NIELSEN LL LIPARI P DELL J GURNANI M MAXWELL E HAJIAN G DEMERS GW
Citation: Ll. Nielsen et al., ADENOVIRUS-MEDIATED P53 GENE-THERAPY SYNERGIZES WITH PACLITAXEL AGAINST HUMAN OVARIAN, MAMMARY, PROSTATE, HEAD AND NECK, AND LIVER-CANCER, Cancer gene therapy, 4(6), 1997, pp. 4-4
EFFICACY OF P53 ADENOVIRUS-MEDIATED GENE-THERAPY AGAINST HUMAN BREAST-CANCER XENOGRAFTS
Authors: NIELSEN LL DELL J MAXWELL E ARMSTRONG L MANEVAL D CATINO JJ
Citation: Ll. Nielsen et al., EFFICACY OF P53 ADENOVIRUS-MEDIATED GENE-THERAPY AGAINST HUMAN BREAST-CANCER XENOGRAFTS, Cancer gene therapy, 4(2), 1997, pp. 129-138
MUTATIONS IN THE TUMOR-SUPPRESSOR GENE P53 IN HUMAN LIVER-CANCER INDUCED BY ALPHA-PARTICLES
Authors: ANDERSSON M JONSSON M NIELSEN LL VYBERG M VISFELDT J STORM HH WALLIN H
Citation: M. Andersson et al., MUTATIONS IN THE TUMOR-SUPPRESSOR GENE P53 IN HUMAN LIVER-CANCER INDUCED BY ALPHA-PARTICLES, Cancer epidemiology, biomarkers & prevention, 4(7), 1995, pp. 765-770
IN WAP-RAS TRANSGENIC MICE, TUMOR PHENOTYPE BUT NOT CYCLOPHOSPHAMIDE-SENSITIVITY IS AFFECTED BY GENETIC BACKGROUND
Authors: NIELSEN LL GURNANI M CATINO JJ TYLER RD
Citation: Ll. Nielsen et al., IN WAP-RAS TRANSGENIC MICE, TUMOR PHENOTYPE BUT NOT CYCLOPHOSPHAMIDE-SENSITIVITY IS AFFECTED BY GENETIC BACKGROUND, Anticancer research, 15(2), 1995, pp. 385-392
STRATEGY FOR DEVELOPING TRANSGENIC ASSAYS FOR SCREENING ANTINEOPLASTIC DRUGS THAT AFFECT TUBULIN POLYMERIZATION
Authors: PORTER GM ARMSTRONG L NIELSEN LL
Citation: Gm. Porter et al., STRATEGY FOR DEVELOPING TRANSGENIC ASSAYS FOR SCREENING ANTINEOPLASTIC DRUGS THAT AFFECT TUBULIN POLYMERIZATION, Laboratory animal science, 45(2), 1995, pp. 145-150
LUNG-CARCINOMA AND MALIGNANT MESOTHELIOMA IN PATIENTS EXPOSED TO THOROTRAST - INCIDENCE, HISTOLOGY AND P53 STATUS
Authors: ANDERSSON M WALLIN H JONSSON M NIELSEN LL VISFELDT J VYBERG M BENNETT WP DEBENEDETTI VMG TRAVIS LB STORM HH
Citation: M. Andersson et al., LUNG-CARCINOMA AND MALIGNANT MESOTHELIOMA IN PATIENTS EXPOSED TO THOROTRAST - INCIDENCE, HISTOLOGY AND P53 STATUS, International journal of cancer, 63(3), 1995, pp. 330-336
Risultati: 1-11 |